Navigation Links
Good asthma control during pregnancy is vital says new review
Date:9/5/2013

Good asthma management during pregnancy is vital during pregnancy as poor asthma control can have adverse effects on maternal and fetal outcomes, says a new review published today (06 September) in The Obstetrician & Gynaecologist (TOG).

Asthma is a common condition that affects around 10% of pregnant women, making it the most common chronic condition in pregnancy.

The review notes that the severity of asthma during pregnancy remains unchanged, worsens or improves in equal proportions. For women with severe asthma, control is more likely to deteriorate (around 60% of cases) compared to women with mild asthma (around 10% of cases). However, the authors conclude that all pregnant women with asthma need to be closely reviewed throughout pregnancy, irrespective of disease severity.

National guidelines recommend the management and treatment for asthma in pregnant women should be generally the same as for non-pregnant women and men, with the intensity of antenatal maternal and fetal surveillance to be based on the severity of their condition.

The authors also note that poor asthma control can lead to adverse effects on maternal and fetal outcomes, with previous studies suggesting poor asthma control is associated with hypertension in pregnancy, a higher frequency of caesarean section and low birth weight. However, the authors emphasise that in most women with well-controlled asthma there are no or minimal additional risks.

The review states the concerns held by mothers and healthcare providers on the potential adverse effects that asthma drugs can have on both the women and their babies, but concludes that it is still safer for women to use asthma therapy in pregnancy to avoid uncontrolled asthma.

Furthermore, asthma does not usually affect labour or delivery with less than a fifth of women experiencing an exacerbation during labour. Additionally, in the postpartum period there is no increased risk of asthma exacerbations and within a few months after delivery a woman's asthma severity typically reverts to its pre-pregnancy level.

Professor Chris Brightling, Professor of Respiratory Medicine and Honorary Consultant Physician, University Hospitals of Leicester and co-author of the paper said:

"Asthma is a widespread condition and poor management during pregnancy can lead to adverse maternal and fetal outcomes.

"Good asthma management to maintain tight control is vital and standard therapy may be safely used in pregnancy to achieve this along with close surveillance from midwives, obstetricians and for women with severe asthma a respiratory physician."

Jason Waugh, TOG Editor-in-chief added:

"Education is key for anyone, especially pregnant women, to manage their asthma. This includes understanding the condition and its treatment options, trigger avoidance, asthma control, adequate use of devices and the importance of adherence to medication.

"Any women who have concerns about their asthma management and management during pregnancy should contact their GP or midwife for further advice."


'/>"/>

Contact: Rebecca Jones
rjones@rcog.org.uk
020-777-26444
Wiley
Source:Eurekalert

Related medicine news :

1. Menopausal women at greater risk for asthma hospitalization
2. Instant Relief for Asthma Delivered by a New Product Called Asthmamist
3. Experiences of racism linked to adult-onset asthma in African-American women
4. Children with allergy, asthma may be at higher risk for ADHD
5. Exercising with Asthma: Tips to Remember
6. Treatment For Asthma
7. “Dramatic Asthma Relief” Teaches People How To Protect Their Body From Asthma – V kool
8. Back to School Asthma Tips for A Safe and Healthy Fall Semester from LivingWithAsthma.net
9. LA BioMed researchers find maternal smoking linked to asthma in the third generation
10. Take your childs word for it on asthma, study finds
11. Researchers find common childhood asthma unconnected to allergens or inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 18, 2017 , ... A ... information and contact points to easily connect elderly veterans of America's armed forces ... elder-care funding. It also conveys material on this year's increase in the Veterans ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network offers physicians ... controlled and non-controlled substances plus the ability to manage orders on their desktop ... now accept electronic prescriptions, according to the Office of the National Coordinator of ...
(Date:2/17/2017)... ... 17, 2017 , ... Corrective Action & Preventive Action for ... Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/capamd      ... action (PA)? , The methods share techniques and tools but they are different ...
(Date:2/17/2017)... ... 17, 2017 , ... MAP Revenue Cycle Solutions (MAP RCS), ... been promoted to Chief Executive Officer. , The need for maximizing reimbursements ... that demands the transition from pay-for-service to pay-for-performance models. By delivering efficient and ...
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across the nation, Onslow ... part by the Hospital Readmission Reduction Program (HRRP), the return of a patient to ... hospitals across the nation. While many providers are struggling to leverage limited resources and ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... , Feb. 19, 2017  nThrive™, an ... cycle portfolio and thought leadership at the 2017 ... a category leader award from KLAS. ... discussion focused on how market trends shape the ... particularly a sophisticated, comprehensive Patient Access solution. The ...
(Date:2/18/2017)... , Feb. 17, 2017  Pharmaceutical companies have long ... products either in development or already on the market.   ... the pharma industry to alter how it manages advisory board ... leader Best Practices, LLC conducted a new study focused on ... ...
(Date:2/17/2017)... , Feb. 17, 2017 Theravance ... Biopharma" or the "Company") today announced the presentation ... potent, and orally administered pan-Janus kinase (JAK) inhibitor ... th Congress of the European Crohn,s and ... Company reported further data from its completed Phase ...
Breaking Medicine Technology: